Individualized prophylactic treatment of patients with hemophilia A to improve effectiveness and optimize product consumption on the example of octocog alpha and rurioctocog alpha pegol. A systematic literature review
Objective: to review the data on the efficacy and consumption of octocog alfa and rurioctoctog alfa pegol in standard prophylaxis and individualized prophylaxis in hemophilia A patients based on published international data. Material and methods: a systematic literature search and review were perfor...
Saved in:
Main Authors: | A. G. Tolkushin (Author), M. E. Holownia-Voloskova (Author), N. L. Pogudina (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety
by: Reinhard Stidl, et al.
Published: (2018) -
Damoctocog Alfa Pegol for Hemophilia A Prophylaxis: An Italian Multicenter Survey
by: Ezio Zanon
Published: (2023) -
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review
by: Mark T. Reding, et al.
Published: (2024) -
Optimization of the colloidal properties of chitosan nanoparticles encapsulating alpha-arbutin
by: Shymaa Hatem, et al.
Published: (2022) -
Generation Alpha
by: Merensiana Hale
Published: (2022)